Catch up on the highlights from LEQVIO: A Bold Way Forward
Watch the videos below for key takeaways from a 2-part LEQVIO CONNECT event,
featuring leaders and experts in cardiovascular health
LEQVIO: A Bold Way Forward
In this overview presentation, learn about what makes LEQVIO clinical profile and dosing different.
Unmet Need in Patients With ASCVD
Dr Pam Taub and Dr Alan S. Brown provide insights on the state of cardiovascular disease and what makes LEQVIO such a vital treatment option for certain patients with ASCVD.
Lowering LDL-C With LEQVIO: Clinical Trial Data Overview
Dr Alan S. Brown dives deeper into pivotal phase III clinical trial data for LEQVIO, for patients with ASCVD, with a focus on efficacy and safety.
Dosing and Administration: How to Give LEQVIO to Your Patients
Dr Alan S. Brown shares details on the LEQVIO dosing regimen—two doses a year after the first year—while highlighting other key information, including product storage, handling, and administration.1
Patients Who Could Benefit From LEQVIO
Dr Pam Taub and Dr Alan S. Brown describe a few types of patients from their clinics who are struggling to achieve the recommended LDL-C target with diet and statin therapy and could benefit from additional treatment options.
LEQVIO via Buy-and-Bill With In-Office Administration
Find out more about acquiring HCP-administered products like LEQVIO through Buy-and-Bill, the primary method for specialty drugs covered under the medical benefit.
LEQVIO via Referral to an Alternate Injection Center (AIC)
If Buy-and-Bill is not your method of choice for acquiring LEQVIO, get details on how you can refer patients to an AIC to handle ordering, administration, and reimbursement. Visit LEQVIO-locator.com to find an AIC.
LEQVIO via Specialty Pharmacy
Gain insights into a third acquisition option for patients to acquire LEQVIO: a specialty pharmacy for in-office administration.
LEQVIO Billing and Coding Information
Learn more about best practices for billing, coding, and reimbursement for HCP-administered products like LEQVIO with Bobbi Buell.
Recap the LEQVIO
Take a moment for a refresh of the entire LEQVIO
clinical story with insights into efficacy, dosing,
safety, and more!
Learn more about what makes LEQVIO different
Download the infographics below to find out even more about LEQVIO
LEQVIO: From Discovery to Development
ORION-10 Clinical Trial Design
Discover Clinical Efficacy & Safety
Explore the MOA
Dive Into siRNA Technology
THERE'S MORE TO KNOW ABOUT LEQVIO
Discover what makes LEQVIO dosing differentDIVE INTO DOSING
AIC, alternate infusion center; ASCVD, atherosclerotic cardiovascular disease; MOA, mechanism of action; siRNA, small interfering RNA.